An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

References

• Evans C, Beland SG, Kulaga S, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40:195–210.
   PubMed Web of Science ®Google Scholar
• Lublin FD. New multiple sclerosis phenotypic classification. Eur Neurol. 2014;72:1–5.
   PubMed Web of Science ®Google Scholar
• Bass A, Van Wijmeersch B, Mayer L, et al. Impact of multiple sclerosis on patients’ daily activities, emotional well-being and relationships: results of the global vsMS™ survey. Neurology. 2017;88:P3 334.
   Google Scholar
• Chiu C, Bishop M, Pionke JJ, et al. Barriers to the accessibility and continuity of health-care services in people with multiple sclerosis. Int J MS Care. 2017;19:313–321.
   PubMedGoogle Scholar
• Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84:191–215.
   PubMed Web of Science ®Google Scholar
• Barlow J, Turner A, Edwards R, et al. A randomised controlled trial of lay-led self-management for people with multiple sclerosis. Patient Educ Couns. 2009;77:81–89.
   PubMed Web of Science ®Google Scholar
• Ennis M, Thain J, Boggild M, et al. A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clin Rehab. 2006;20:783–792.
   PubMed Web of Science ®Google Scholar
• Forman AC, Lincoln NB. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehab. 2010;24:211–221.
   PubMed Web of Science ®Google Scholar
• Lincoln NB, Yuill F, Holmes J, et al. Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial. Mult Scler. 2011;17:1250–1257.
   PubMed Web of Science ®Google Scholar
• Mathiowetz VG, Finlayson ML, Matuska KM, et al. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler. 2005;11:592–601.
   PubMed Web of Science ®Google Scholar
• Miller DM, Moore SM, Fox RJ, et al. Web-based self-management for patients with multiple sclerosis: a practical, randomized trial. Telemed J E Health. 2011;17:5–13.
   PubMed Web of Science ®Google Scholar
• Stuifbergen AK, Becker H, Blozis S, et al. A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch Phys Med Rehab. 2003;84:467–476.
   PubMed Web of Science ®Google Scholar
• Stuifbergen AK, Becker H, Perez F, et al. A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis. Clin Rehab. 2012;26:882–893.
   PubMed Web of Science ®Google Scholar
• Motl RW, Dlugonski D, Wojcicki TR, et al. Internet intervention for increasing physical activity in persons with multiple sclerosis. Mult Scler. 2011;17:116–128.
   PubMed Web of Science ®Google Scholar
• Jongen PJ, Heerings M, Ruimschotel R, et al. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later. BMC Res Notes. 2016;9:375.
   PubMedGoogle Scholar
• Jongen P, van Mastrigt G, Heerings M, et al. Intensive social cognitive treatment of self-efficacy in relapsing remitting multiple sclerosis patients: a randomized, open-label, controlled trial. PLOS One. Forthcoming.
   Google Scholar
• Uitdehaag B, Kobelt G, Berg J, et al. New insights into the burden and costs of multiple sclerosis in Europe: results for the Netherlands. Mult Scler. 2017;23:117–129.
   PubMed Web of Science ®Google Scholar
• 64th WMA General Assembly. Ethical principles for medical research involving human subjects Fortaleza, Brazil, October 2013, version 2013 [cited 2019 May 6]. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
   Google Scholar
• Jongen PJ, Heerings M, Ruimschotel R, et al. An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol. BMC Neurol. 2016;16:81.
   PubMed Web of Science ®Google Scholar
• Neurology. Multiple sclerosis. Utrecht, The Netherlands: Dutch Federation of medical specialists. 2012 [cited 2019 May 06]. Available from: https://richtlijnendatabase.nl/richtlijn/acute_neurologie/acute_neurologie_bij_multiple_sclerose/immunomodulerende_en_-suppressieve_beh_ms.html
   Google Scholar
• Schwartz CE, Coulthard-Morris L, Zeng Q, et al. Measuring self-efficacy in people with multiple sclerosis: a validation study. Arch Phys Med Rehabil. 1996;77:394–398.
   PubMed Web of Science ®Google Scholar
• Versteegh M, Vermeulen K, Evers S, et al. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343–352.
   PubMed Web of Science ®Google Scholar
• IJzerman M, Al M, de Boer A, et al. Guideline for performing economic evaluation research in Health Care (in Dutch). Diemen: Care Institute the Netherlands; 2015.
   Google Scholar
• Versteegh M, Knies S, Brouwer W. From good to better: new Dutch guidelines for economic evaluations in healthcare. Pharmacoeconomics. 2016;34:1071–1074.
   PubMed Web of Science ®Google Scholar
• Hakkaart-van Roijen L, van der Linden M, Bouwmans C, et al. Guideline for cost research: Methodology and reference prices for economic evaluations in healthcare (In Dutch). Rotterdam, The Netherlands: iMTA Erasmus University Rotterdam; 2015.
   Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–592.
   PubMed Web of Science ®Google Scholar
• Raad voor Volksgezondheid en Samenleving (RVS). Zinnige en duurzame zorg. Zoetermeer, The Netherlands: RVS; 2006. Dutch.
   Google Scholar
• van Hout B, Janssen MF, Feng Y-S, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–715.
   PubMed Web of Science ®Google Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292.
   PubMed Web of Science ®Google Scholar
• Sogaard R, Christensen FB, Videbaek TS, et al. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain. Value Health. 2009;12:606–612.
   PubMed Web of Science ®Google Scholar
• Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859.
   PubMed Web of Science ®Google Scholar
• Jongen PJ, Ruimschotel RP, Museler-Kreijns YM, et al. Improved health-related quality of life, participation, and autonomy in patients with treatment-resistant chronic pain after an intensive social cognitive intervention with the participation of support partners. JPR. 2017;10:2725–2738.
   Google Scholar
• Dennison L, Moss-Morris R. Cognitive–behavioral therapy: what benefits can it offer people with multiple sclerosis? Expert Rev Neurother. 2010;10:1383–1390.
   PubMed Web of Science ®Google Scholar
• Wendebourg MJ, Heesen C, Finlayson M, et al. Patient education for people with multiple sclerosis-associated fatigue: a systematic review. PloS One. 2017;12:e0173025.
   PubMed Web of Science ®Google Scholar
• Graziano F, Calandri E, Borghi M, et al. The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial. Clin Rehabil. 2014;28:264–274.
   PubMed Web of Science ®Google Scholar
• Kalina JT, Hinojosa J, Strober L, et al. Randomized controlled trial to improve self-efficacy in people with multiple sclerosis: the Community Reintegration for Socially Isolated Patients (CRISP) program. Am J Occup Ther. 2018;72:7205205030p1.
   PubMed Web of Science ®Google Scholar
• Plow M, Bethoux F, Mai K, et al. A formative evaluation of customized pamphlets to promote physical activity and symptom self-management in women with multiple sclerosis. Health Educ Res. 2014;29:883–896.
   PubMed Web of Science ®Google Scholar
• Suh Y, Motl RW, Olsen C, et al. Pilot trial of a social cognitive theory-based physical activity intervention delivered by nonsupervised technology in persons with multiple sclerosis. J Phys Act Health. 2015;12:924–930.
   PubMed Web of Science ®Google Scholar
• Thomas S, Thomas PW, Kersten P, et al. A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:1092–1099.
   PubMed Web of Science ®Google Scholar
• Dorstyn D, Roberts R, Murphy G, et al. Online resource to promote vocational interests among job seekers with multiple sclerosis: a randomized controlled trial in Australia. Arch Phys Med Rehabil. 2018;99:272–280.
   PubMed Web of Science ®Google Scholar
• Tosh J, Dixon S, Carter A, et al. Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial. Mult Scler. 2014;20:1123–1130.
   PubMed Web of Science ®Google Scholar
• NICE. Developing NICE guidelines: the manual. Appendix H. 2014 [cited 2019 May 06]. Available from: https://www.nice.org.uk/process/pmg20/resources
   Google Scholar
• NICE. Developing NICE guidelines: the manual. 2014 [cited 2019 May 6]. Available from: https://www.nice.org.uk/process/pmg20/chapter/introduction-and-overview
   Google Scholar
• Kuspinar A, Mayo NE. A review of the psychometric properties of generic utility measures in multiple sclerosis. Pharmacoeconomics. 2014;32:759–773.
   PubMed Web of Science ®Google Scholar
• Brazier J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873–884.
   PubMed Web of Science ®Google Scholar
• Fogarty E, Walsh C, Adams R, et al. Relating health-related quality of life to disability progression in multiple sclerosis, using the 5-level EQ-5D. Mult Scler. 2013;19:1190–1196.
   PubMedGoogle Scholar
• Fisk JD, Brown MG, Sketris IS, et al. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry. 2005;76:58–63.
   PubMed Web of Science ®Google Scholar
• Kobelt G, Eriksson J, Phillips G, et al. The burden of multiple sclerosis 2015: methods of data collection, assessment and analysis of costs, quality of life and symptoms. Mult Scler. 2017;23:4–16.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452.
   PubMed Web of Science ®Google Scholar
• Petrou S, Hockley C. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ. 2005;14:1169–1189.
   PubMed Web of Science ®Google Scholar
• Davis JC, Liu-Ambrose T, Khan KM, et al. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions. Osteoporos Int. 2012;23:1849–1857.
   PubMed Web of Science ®Google Scholar
• Joore M, Brunenberg D, Nelemans P, et al. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health. 2010;13:222–229.
   PubMed Web of Science ®Google Scholar
• Willems DC, Joore MA, Hendriks JJ, et al. Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial. Cost Eff Resour Alloc. 2007;5:10.
   PubMedGoogle Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16:231–250.
   PubMed Web of Science ®Google Scholar
• Drummond M, Schulper MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2016.
   Google Scholar
• Wagner MM, Melnyk P, Rindress D. Systematic review of guideline recommendations on comparator selection in health economic evaluations. Value Health. 2012;15:A168.
   Google Scholar
• Ng A, Kennedy P, Hutchinson B, et al. Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis. Disabil Rehabil. 2013;35:1039–1044.
   PubMed Web of Science ®Google Scholar